풍전약품

298060KOSDAQSector: Pharma & Biotech

₩2,545▲ 1.19%Market cap ₩24.5BAs of Jul 21, 2026 close · updated once daily

Grade B61.1 ptsTop 31% of 2,523 stocks

Financial strength

53.9

Price attractiveness

69.3

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

ⓘ Growth momentum not rated — will be included automatically as data accumulates

Financial strength

53.9

How much debt does it carry relative to equity?

Debt-to-equity ratio

44.1%

✓ Above median · Top 42.1% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

227.7%

✓ Above median · Top 41.7% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

-19.0%

✗ Below median · Top 59.9% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

0.6%

✓ Above median · Top 40.9% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

69.3

Is the price expensive relative to earnings?

P/E (price-to-earnings)

121.1x

✓ Above median · Top 38.4% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

0.68x

✓ Above median · Top 23% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15